Medical Care
Global HIV Clinical Trials Market Research Report 2025
- Mar 11, 25
- ID: 120102
- Pages: 82
- Figures: 90
- Views: 7
The global market for HIV Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
HIV clinical trials help researchers find better ways to prevent, detect, or treat HIV. Examples of HIVclinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV.
North American market for HIV Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HIV Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for HIV Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of HIV Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc., Bionor Holding AS, Charles River Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Clinical Trials.
The HIV Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HIV clinical trials help researchers find better ways to prevent, detect, or treat HIV. Examples of HIVclinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV.
North American market for HIV Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HIV Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for HIV Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of HIV Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc., Bionor Holding AS, Charles River Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Clinical Trials.
The HIV Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global HIV Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Non Profit Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Clinical Trials Market Perspective (2020-2031)
2.2 Global HIV Clinical Trials Growth Trends by Region
2.2.1 Global HIV Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HIV Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 HIV Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 HIV Clinical Trials Market Dynamics
2.3.1 HIV Clinical Trials Industry Trends
2.3.2 HIV Clinical Trials Market Drivers
2.3.3 HIV Clinical Trials Market Challenges
2.3.4 HIV Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Clinical Trials Players by Revenue
3.1.1 Global Top HIV Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global HIV Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global HIV Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HIV Clinical Trials Revenue
3.4 Global HIV Clinical Trials Market Concentration Ratio
3.4.1 Global HIV Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Clinical Trials Revenue in 2024
3.5 Global Key Players of HIV Clinical Trials Head office and Area Served
3.6 Global Key Players of HIV Clinical Trials, Product and Application
3.7 Global Key Players of HIV Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Clinical Trials Breakdown Data by Type
4.1 Global HIV Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global HIV Clinical Trials Forecasted Market Size by Type (2026-2031)
5 HIV Clinical Trials Breakdown Data by Application
5.1 Global HIV Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global HIV Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HIV Clinical Trials Market Size (2020-2031)
6.2 North America HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HIV Clinical Trials Market Size by Country (2020-2025)
6.4 North America HIV Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Clinical Trials Market Size (2020-2031)
7.2 Europe HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HIV Clinical Trials Market Size by Country (2020-2025)
7.4 Europe HIV Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific HIV Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HIV Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific HIV Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Clinical Trials Market Size (2020-2031)
9.2 Latin America HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HIV Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America HIV Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HIV Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa HIV Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PPD Inc.
11.1.1 PPD Inc. Company Details
11.1.2 PPD Inc. Business Overview
11.1.3 PPD Inc. HIV Clinical Trials Introduction
11.1.4 PPD Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.1.5 PPD Inc. Recent Development
11.2 IQVIA Inc.
11.2.1 IQVIA Inc. Company Details
11.2.2 IQVIA Inc. Business Overview
11.2.3 IQVIA Inc. HIV Clinical Trials Introduction
11.2.4 IQVIA Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.2.5 IQVIA Inc. Recent Development
11.3 Parexel International Corporation
11.3.1 Parexel International Corporation Company Details
11.3.2 Parexel International Corporation Business Overview
11.3.3 Parexel International Corporation HIV Clinical Trials Introduction
11.3.4 Parexel International Corporation Revenue in HIV Clinical Trials Business (2020-2025)
11.3.5 Parexel International Corporation Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Details
11.4.2 ICON plc Business Overview
11.4.3 ICON plc HIV Clinical Trials Introduction
11.4.4 ICON plc Revenue in HIV Clinical Trials Business (2020-2025)
11.4.5 ICON plc Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Details
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health HIV Clinical Trials Introduction
11.5.4 Syneos Health Revenue in HIV Clinical Trials Business (2020-2025)
11.5.5 Syneos Health Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec HIV Clinical Trials Introduction
11.6.4 WuXi AppTec Revenue in HIV Clinical Trials Business (2020-2025)
11.6.5 WuXi AppTec Recent Development
11.7 Janssen Global Services, LLC
11.7.1 Janssen Global Services, LLC Company Details
11.7.2 Janssen Global Services, LLC Business Overview
11.7.3 Janssen Global Services, LLC HIV Clinical Trials Introduction
11.7.4 Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2020-2025)
11.7.5 Janssen Global Services, LLC Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Details
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. HIV Clinical Trials Introduction
11.8.4 Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Bionor Holding AS
11.9.1 Bionor Holding AS Company Details
11.9.2 Bionor Holding AS Business Overview
11.9.3 Bionor Holding AS HIV Clinical Trials Introduction
11.9.4 Bionor Holding AS Revenue in HIV Clinical Trials Business (2020-2025)
11.9.5 Bionor Holding AS Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories HIV Clinical Trials Introduction
11.10.4 Charles River Laboratories Revenue in HIV Clinical Trials Business (2020-2025)
11.10.5 Charles River Laboratories Recent Development
11.11 GSK plc.
11.11.1 GSK plc. Company Details
11.11.2 GSK plc. Business Overview
11.11.3 GSK plc. HIV Clinical Trials Introduction
11.11.4 GSK plc. Revenue in HIV Clinical Trials Business (2020-2025)
11.11.5 GSK plc. Recent Development
11.12 SGS SA
11.12.1 SGS SA Company Details
11.12.2 SGS SA Business Overview
11.12.3 SGS SA HIV Clinical Trials Introduction
11.12.4 SGS SA Revenue in HIV Clinical Trials Business (2020-2025)
11.12.5 SGS SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global HIV Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Non Profit Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Clinical Trials Market Perspective (2020-2031)
2.2 Global HIV Clinical Trials Growth Trends by Region
2.2.1 Global HIV Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HIV Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 HIV Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 HIV Clinical Trials Market Dynamics
2.3.1 HIV Clinical Trials Industry Trends
2.3.2 HIV Clinical Trials Market Drivers
2.3.3 HIV Clinical Trials Market Challenges
2.3.4 HIV Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Clinical Trials Players by Revenue
3.1.1 Global Top HIV Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global HIV Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global HIV Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HIV Clinical Trials Revenue
3.4 Global HIV Clinical Trials Market Concentration Ratio
3.4.1 Global HIV Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Clinical Trials Revenue in 2024
3.5 Global Key Players of HIV Clinical Trials Head office and Area Served
3.6 Global Key Players of HIV Clinical Trials, Product and Application
3.7 Global Key Players of HIV Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Clinical Trials Breakdown Data by Type
4.1 Global HIV Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global HIV Clinical Trials Forecasted Market Size by Type (2026-2031)
5 HIV Clinical Trials Breakdown Data by Application
5.1 Global HIV Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global HIV Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HIV Clinical Trials Market Size (2020-2031)
6.2 North America HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HIV Clinical Trials Market Size by Country (2020-2025)
6.4 North America HIV Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Clinical Trials Market Size (2020-2031)
7.2 Europe HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HIV Clinical Trials Market Size by Country (2020-2025)
7.4 Europe HIV Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific HIV Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HIV Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific HIV Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Clinical Trials Market Size (2020-2031)
9.2 Latin America HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HIV Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America HIV Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa HIV Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HIV Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa HIV Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PPD Inc.
11.1.1 PPD Inc. Company Details
11.1.2 PPD Inc. Business Overview
11.1.3 PPD Inc. HIV Clinical Trials Introduction
11.1.4 PPD Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.1.5 PPD Inc. Recent Development
11.2 IQVIA Inc.
11.2.1 IQVIA Inc. Company Details
11.2.2 IQVIA Inc. Business Overview
11.2.3 IQVIA Inc. HIV Clinical Trials Introduction
11.2.4 IQVIA Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.2.5 IQVIA Inc. Recent Development
11.3 Parexel International Corporation
11.3.1 Parexel International Corporation Company Details
11.3.2 Parexel International Corporation Business Overview
11.3.3 Parexel International Corporation HIV Clinical Trials Introduction
11.3.4 Parexel International Corporation Revenue in HIV Clinical Trials Business (2020-2025)
11.3.5 Parexel International Corporation Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Details
11.4.2 ICON plc Business Overview
11.4.3 ICON plc HIV Clinical Trials Introduction
11.4.4 ICON plc Revenue in HIV Clinical Trials Business (2020-2025)
11.4.5 ICON plc Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Details
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health HIV Clinical Trials Introduction
11.5.4 Syneos Health Revenue in HIV Clinical Trials Business (2020-2025)
11.5.5 Syneos Health Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec HIV Clinical Trials Introduction
11.6.4 WuXi AppTec Revenue in HIV Clinical Trials Business (2020-2025)
11.6.5 WuXi AppTec Recent Development
11.7 Janssen Global Services, LLC
11.7.1 Janssen Global Services, LLC Company Details
11.7.2 Janssen Global Services, LLC Business Overview
11.7.3 Janssen Global Services, LLC HIV Clinical Trials Introduction
11.7.4 Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2020-2025)
11.7.5 Janssen Global Services, LLC Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Details
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. HIV Clinical Trials Introduction
11.8.4 Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2020-2025)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Bionor Holding AS
11.9.1 Bionor Holding AS Company Details
11.9.2 Bionor Holding AS Business Overview
11.9.3 Bionor Holding AS HIV Clinical Trials Introduction
11.9.4 Bionor Holding AS Revenue in HIV Clinical Trials Business (2020-2025)
11.9.5 Bionor Holding AS Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories HIV Clinical Trials Introduction
11.10.4 Charles River Laboratories Revenue in HIV Clinical Trials Business (2020-2025)
11.10.5 Charles River Laboratories Recent Development
11.11 GSK plc.
11.11.1 GSK plc. Company Details
11.11.2 GSK plc. Business Overview
11.11.3 GSK plc. HIV Clinical Trials Introduction
11.11.4 GSK plc. Revenue in HIV Clinical Trials Business (2020-2025)
11.11.5 GSK plc. Recent Development
11.12 SGS SA
11.12.1 SGS SA Company Details
11.12.2 SGS SA Business Overview
11.12.3 SGS SA HIV Clinical Trials Introduction
11.12.4 SGS SA Revenue in HIV Clinical Trials Business (2020-2025)
11.12.5 SGS SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global HIV Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global HIV Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HIV Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global HIV Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global HIV Clinical Trials Market Share by Region (2020-2025)
Table 10. Global HIV Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global HIV Clinical Trials Market Share by Region (2026-2031)
Table 12. HIV Clinical Trials Market Trends
Table 13. HIV Clinical Trials Market Drivers
Table 14. HIV Clinical Trials Market Challenges
Table 15. HIV Clinical Trials Market Restraints
Table 16. Global HIV Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global HIV Clinical Trials Market Share by Players (2020-2025)
Table 18. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2024)
Table 19. Ranking of Global Top HIV Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by HIV Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of HIV Clinical Trials, Headquarters and Area Served
Table 22. Global Key Players of HIV Clinical Trials, Product and Application
Table 23. Global Key Players of HIV Clinical Trials, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global HIV Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global HIV Clinical Trials Revenue Market Share by Type (2020-2025)
Table 27. Global HIV Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global HIV Clinical Trials Revenue Market Share by Type (2026-2031)
Table 29. Global HIV Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global HIV Clinical Trials Revenue Market Share by Application (2020-2025)
Table 31. Global HIV Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global HIV Clinical Trials Revenue Market Share by Application (2026-2031)
Table 33. North America HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific HIV Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific HIV Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific HIV Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 48. PPD Inc. Company Details
Table 49. PPD Inc. Business Overview
Table 50. PPD Inc. HIV Clinical Trials Product
Table 51. PPD Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 52. PPD Inc. Recent Development
Table 53. IQVIA Inc. Company Details
Table 54. IQVIA Inc. Business Overview
Table 55. IQVIA Inc. HIV Clinical Trials Product
Table 56. IQVIA Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 57. IQVIA Inc. Recent Development
Table 58. Parexel International Corporation Company Details
Table 59. Parexel International Corporation Business Overview
Table 60. Parexel International Corporation HIV Clinical Trials Product
Table 61. Parexel International Corporation Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 62. Parexel International Corporation Recent Development
Table 63. ICON plc Company Details
Table 64. ICON plc Business Overview
Table 65. ICON plc HIV Clinical Trials Product
Table 66. ICON plc Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 67. ICON plc Recent Development
Table 68. Syneos Health Company Details
Table 69. Syneos Health Business Overview
Table 70. Syneos Health HIV Clinical Trials Product
Table 71. Syneos Health Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 72. Syneos Health Recent Development
Table 73. WuXi AppTec Company Details
Table 74. WuXi AppTec Business Overview
Table 75. WuXi AppTec HIV Clinical Trials Product
Table 76. WuXi AppTec Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 77. WuXi AppTec Recent Development
Table 78. Janssen Global Services, LLC Company Details
Table 79. Janssen Global Services, LLC Business Overview
Table 80. Janssen Global Services, LLC HIV Clinical Trials Product
Table 81. Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 82. Janssen Global Services, LLC Recent Development
Table 83. Gilead Sciences, Inc. Company Details
Table 84. Gilead Sciences, Inc. Business Overview
Table 85. Gilead Sciences, Inc. HIV Clinical Trials Product
Table 86. Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 87. Gilead Sciences, Inc. Recent Development
Table 88. Bionor Holding AS Company Details
Table 89. Bionor Holding AS Business Overview
Table 90. Bionor Holding AS HIV Clinical Trials Product
Table 91. Bionor Holding AS Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 92. Bionor Holding AS Recent Development
Table 93. Charles River Laboratories Company Details
Table 94. Charles River Laboratories Business Overview
Table 95. Charles River Laboratories HIV Clinical Trials Product
Table 96. Charles River Laboratories Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 97. Charles River Laboratories Recent Development
Table 98. GSK plc. Company Details
Table 99. GSK plc. Business Overview
Table 100. GSK plc. HIV Clinical Trials Product
Table 101. GSK plc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 102. GSK plc. Recent Development
Table 103. SGS SA Company Details
Table 104. SGS SA Business Overview
Table 105. SGS SA HIV Clinical Trials Product
Table 106. SGS SA Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 107. SGS SA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. HIV Clinical Trials Picture
Figure 2. Global HIV Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HIV Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Phase I Features
Figure 5. Phase II Features
Figure 6. Phase III Features
Figure 7. Phase IV Features
Figure 8. Global HIV Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global HIV Clinical Trials Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 11. Non Profit Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. HIV Clinical Trials Report Years Considered
Figure 14. Global HIV Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global HIV Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global HIV Clinical Trials Market Share by Region: 2024 VS 2031
Figure 17. Global HIV Clinical Trials Market Share by Players in 2024
Figure 18. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by HIV Clinical Trials Revenue in 2024
Figure 20. North America HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America HIV Clinical Trials Market Share by Country (2020-2031)
Figure 22. United States HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe HIV Clinical Trials Market Share by Country (2020-2031)
Figure 26. Germany HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific HIV Clinical Trials Market Share by Region (2020-2031)
Figure 34. China HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America HIV Clinical Trials Market Share by Country (2020-2031)
Figure 42. Mexico HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa HIV Clinical Trials Market Share by Country (2020-2031)
Figure 46. Turkey HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. PPD Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 50. IQVIA Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 51. Parexel International Corporation Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 52. ICON plc Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 53. Syneos Health Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 54. WuXi AppTec Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 55. Janssen Global Services, LLC Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 56. Gilead Sciences, Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 57. Bionor Holding AS Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 58. Charles River Laboratories Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 59. GSK plc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 60. SGS SA Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global HIV Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global HIV Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HIV Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global HIV Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global HIV Clinical Trials Market Share by Region (2020-2025)
Table 10. Global HIV Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global HIV Clinical Trials Market Share by Region (2026-2031)
Table 12. HIV Clinical Trials Market Trends
Table 13. HIV Clinical Trials Market Drivers
Table 14. HIV Clinical Trials Market Challenges
Table 15. HIV Clinical Trials Market Restraints
Table 16. Global HIV Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global HIV Clinical Trials Market Share by Players (2020-2025)
Table 18. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2024)
Table 19. Ranking of Global Top HIV Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by HIV Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of HIV Clinical Trials, Headquarters and Area Served
Table 22. Global Key Players of HIV Clinical Trials, Product and Application
Table 23. Global Key Players of HIV Clinical Trials, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global HIV Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global HIV Clinical Trials Revenue Market Share by Type (2020-2025)
Table 27. Global HIV Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global HIV Clinical Trials Revenue Market Share by Type (2026-2031)
Table 29. Global HIV Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global HIV Clinical Trials Revenue Market Share by Application (2020-2025)
Table 31. Global HIV Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global HIV Clinical Trials Revenue Market Share by Application (2026-2031)
Table 33. North America HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific HIV Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific HIV Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific HIV Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa HIV Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa HIV Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa HIV Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 48. PPD Inc. Company Details
Table 49. PPD Inc. Business Overview
Table 50. PPD Inc. HIV Clinical Trials Product
Table 51. PPD Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 52. PPD Inc. Recent Development
Table 53. IQVIA Inc. Company Details
Table 54. IQVIA Inc. Business Overview
Table 55. IQVIA Inc. HIV Clinical Trials Product
Table 56. IQVIA Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 57. IQVIA Inc. Recent Development
Table 58. Parexel International Corporation Company Details
Table 59. Parexel International Corporation Business Overview
Table 60. Parexel International Corporation HIV Clinical Trials Product
Table 61. Parexel International Corporation Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 62. Parexel International Corporation Recent Development
Table 63. ICON plc Company Details
Table 64. ICON plc Business Overview
Table 65. ICON plc HIV Clinical Trials Product
Table 66. ICON plc Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 67. ICON plc Recent Development
Table 68. Syneos Health Company Details
Table 69. Syneos Health Business Overview
Table 70. Syneos Health HIV Clinical Trials Product
Table 71. Syneos Health Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 72. Syneos Health Recent Development
Table 73. WuXi AppTec Company Details
Table 74. WuXi AppTec Business Overview
Table 75. WuXi AppTec HIV Clinical Trials Product
Table 76. WuXi AppTec Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 77. WuXi AppTec Recent Development
Table 78. Janssen Global Services, LLC Company Details
Table 79. Janssen Global Services, LLC Business Overview
Table 80. Janssen Global Services, LLC HIV Clinical Trials Product
Table 81. Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 82. Janssen Global Services, LLC Recent Development
Table 83. Gilead Sciences, Inc. Company Details
Table 84. Gilead Sciences, Inc. Business Overview
Table 85. Gilead Sciences, Inc. HIV Clinical Trials Product
Table 86. Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 87. Gilead Sciences, Inc. Recent Development
Table 88. Bionor Holding AS Company Details
Table 89. Bionor Holding AS Business Overview
Table 90. Bionor Holding AS HIV Clinical Trials Product
Table 91. Bionor Holding AS Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 92. Bionor Holding AS Recent Development
Table 93. Charles River Laboratories Company Details
Table 94. Charles River Laboratories Business Overview
Table 95. Charles River Laboratories HIV Clinical Trials Product
Table 96. Charles River Laboratories Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 97. Charles River Laboratories Recent Development
Table 98. GSK plc. Company Details
Table 99. GSK plc. Business Overview
Table 100. GSK plc. HIV Clinical Trials Product
Table 101. GSK plc. Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 102. GSK plc. Recent Development
Table 103. SGS SA Company Details
Table 104. SGS SA Business Overview
Table 105. SGS SA HIV Clinical Trials Product
Table 106. SGS SA Revenue in HIV Clinical Trials Business (2020-2025) & (US$ Million)
Table 107. SGS SA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. HIV Clinical Trials Picture
Figure 2. Global HIV Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HIV Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Phase I Features
Figure 5. Phase II Features
Figure 6. Phase III Features
Figure 7. Phase IV Features
Figure 8. Global HIV Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global HIV Clinical Trials Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 11. Non Profit Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. HIV Clinical Trials Report Years Considered
Figure 14. Global HIV Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global HIV Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global HIV Clinical Trials Market Share by Region: 2024 VS 2031
Figure 17. Global HIV Clinical Trials Market Share by Players in 2024
Figure 18. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by HIV Clinical Trials Revenue in 2024
Figure 20. North America HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America HIV Clinical Trials Market Share by Country (2020-2031)
Figure 22. United States HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe HIV Clinical Trials Market Share by Country (2020-2031)
Figure 26. Germany HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific HIV Clinical Trials Market Share by Region (2020-2031)
Figure 34. China HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America HIV Clinical Trials Market Share by Country (2020-2031)
Figure 42. Mexico HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa HIV Clinical Trials Market Share by Country (2020-2031)
Figure 46. Turkey HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE HIV Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. PPD Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 50. IQVIA Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 51. Parexel International Corporation Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 52. ICON plc Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 53. Syneos Health Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 54. WuXi AppTec Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 55. Janssen Global Services, LLC Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 56. Gilead Sciences, Inc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 57. Bionor Holding AS Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 58. Charles River Laboratories Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 59. GSK plc. Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 60. SGS SA Revenue Growth Rate in HIV Clinical Trials Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232